IRWD Ironwood Pharmaceuticals Inc.

Fundamentals / CIK 0001446847 / USD

Ironwood Pharmaceuticals Inc. reported $400.3M in revenue and net income of $149.6M for the trailing twelve months ended September 30, 2026 (up 9.0% year over year), with a 62.9% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open IRWD in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$626.7M$313.3M$0-$982.0MFY 2016 Revenue: $274.0MFY 2016 Net Income: -$81.71M2016FY 2017 Revenue: $298.3MFY 2017 Net Income: -$116.9M2017FY 2018 Revenue: $346.6MFY 2018 Net Income: -$282.4M2018FY 2019 Revenue: $428.4MFY 2019 Net Income: $21.50M2019FY 2020 Revenue: $389.5MFY 2020 Net Income: $106.2M2020FY 2021 Revenue: $413.8MFY 2021 Net Income: $528.4M2021FY 2022 Revenue: $410.6MFY 2022 Net Income: $175.1M2022FY 2023 Revenue: $442.7MFY 2023 Net Income: -$1.00B2023FY 2024 Revenue: $351.4MFY 2024 Net Income: $880K2024FY 2025 Revenue: $296.2MFY 2025 Net Income: $24.02M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $296.2M $351.4M $442.7M $410.6M $413.8M $389.5M $428.4M $346.6M $298.3M $274.0M
Cost of Revenue -- -- -- -- -- $3.14M $23.88M $32.75M $19.10M $1.87M
Gross Profit -- -- -- -- -- $386.4M $404.5M $313.9M $279.2M $272.1M
Research & Development $95.14M $111.4M $116.1M $44.27M $70.41M $88.06M $115.0M $101.1M $88.14M $139.5M
Selling, General & Admin $82.26M $144.3M $158.3M $116.0M $111.1M $140.0M $172.4M $219.7M $231.2M $173.3M
Operating Income $98.50M $93.12M -$945.4M $250.3M $232.3M $142.9M $120.1M -$150.7M -$15.36M -$51.87M
EBITDA $99.60M $94.32M -$944.2M $251.7M $233.8M $145.2M $125.7M -$146.8M -$8.96M -$41.59M
Interest Expense $32.75M $33.03M $21.63M $7.60M $31.15M $29.48M $36.60M $37.72M $36.37M $39.15M
Income Before Tax $70.03M $65.20M -$948.1M $252.4M $200.7M $108.9M $58.94M -$194.1M -- --
Income Tax Expense $46.01M $64.32M $83.49M $77.36M -$327.8M $2.69M $0 $0 $0 $0
Net Income $24.02M $880K -$1.00B $175.1M $528.4M $106.2M $21.50M -$282.4M -$116.9M -$81.71M
Basic EPS $0.15 $0.01 -$6.45 $1.13 $3.26 $0.67 $0.14 -$1.85 -$0.78 -$0.56
Diluted EPS $0.15 $0.01 -$6.45 $0.96 $3.21 $0.66 $0.14 -$1.85 -$0.78 -$0.56
Basic Shares Outstanding 161.8M 159.1M 155.4M 154.4M 162.2M 159.4M 156.0M 152.6M 149.0M 144.9M
Diluted Shares Outstanding 163.0M 160.1M 155.4M 186.3M 164.4M 160.7M 156.0M 152.6M 149.0M 144.9M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $133.0M $113.0M $106.5M $47.71M $122.1M $85.24M $41.14M $90.55M
Research & Development $28.35M $22.42M $21.94M $21.86M $22.47M $23.37M $27.43M $25.39M
Selling, General & Admin $11.55M $11.31M $12.03M $19.29M $21.91M $16.80M $24.26M $33.59M
Operating Income $93.13M $79.31M $72.57M $6.80M $75.48M $45.32M -$29.11M $31.49M
EBITDA $93.59M $79.76M $73.02M $7.26M $75.96M $45.79M -$28.63M $31.98M
Interest Expense $6.20M $7.20M $9.14M $7.89M $8.43M $8.36M $8.07M $8.91M
Income Before Tax $87.60M $73.73M $65.17M $455K $68.02M $37.82M -$36.27M $24.00M
Income Tax Expense $27.76M $22.44M $24.40M $2.73M $27.94M $14.22M $1.11M $21.74M
Net Income $59.84M $51.29M $40.77M -$2.28M $40.08M $23.60M -$37.39M $2.26M
Basic EPS $0.36 $0.31 $0.25 -$0.01 $0.25 $0.15 -$0.23 $0.01
Diluted EPS $0.36 $0.31 $0.24 -$0.01 $0.23 $0.14 -$0.23 $0.01
Basic Shares Outstanding 164.9M 164.4M 163.5M -- 162.2M 161.7M 161.0M --
Diluted Shares Outstanding 168.2M 167.2M 166.7M -- 177.8M 176.8M 161.0M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $215.5M $88.56M $92.15M $656.2M $620.1M $362.6M $177.0M $173.2M $125.7M $54.00M
Short-Term Investments -- -- -- -- -- -- -- -- $95.68M --
Cash & Short-Term Investments $215.5M $88.56M $92.15M $656.2M $620.1M $362.6M $177.0M $173.2M $221.4M $54.00M
Accounts Receivable, Net $46.74M $81.89M $129.1M $115.5M $114.0M $122.4M $11.28M $20.99M $3.19M $933K
Inventory -- -- -- -- -- -- $648K -- $735K $1.08M
Total Current Assets $274.2M $182.4M $233.3M $780.6M $745.2M $495.8M $306.9M $266.4M $311.6M $380.2M
Property, Plant & Equipment, Net $3.41M $4.50M $5.58M $6.29M $7.58M $8.93M $12.43M $7.65M $17.27M $20.51M
Goodwill -- -- -- -- -- -- $785K $785K $785K $785K
Intangible Assets $2.04M $2.86M $3.68M -- -- -- -- -- $159.9M $166.1M
Other Non-Current Assets $4.50M $5.92M $3.61M $847K $1.00M $943K $790K $89K $870K $1.46M
Total Non-Current Assets $122.7M $168.5M $237.8M $319.9M $381.7M $63.40M $95.90M $65.61M $294.1M $329.6M
Total Assets $396.9M $350.9M $471.1M $1.10B $1.13B $559.2M $402.7M $332.1M $605.7M $709.8M
Accounts Payable $2.90M $2.13M $7.83M $483K $935K $661K $3.98M $14.89M $15.96M $17.70M
Deferred Revenue (Current) $1.11M $2.03M $2.62M -- -- -- $875K -- -- --
Total Current Liabilities $242.2M $38.85M $276.1M $25.52M $161.7M $32.17M $40.93M $119.5M $66.03M $91.13M
Long-Term Debt -- $199.0M $397.9M $396.3M $454.2M $430.3M -- -- -- --
Other Non-Current Liabilities $21.65M $17.11M $28.41M $9.77M $3.50M $1.76M $734K $2.53M $5.06M $8.19M
Total Non-Current Liabilities $416.5M $613.4M $541.3M $422.6M $359.3M $464.4M $455.1M $408.9M $529.8M $552.0M
Total Liabilities $658.7M $652.2M $817.4M $448.1M $521.0M $496.6M $496.0M $528.4M $595.8M $643.1M
Total Debt (incl. Leases) $13.12M $214.5M $415.5M $415.9M $475.8M $453.7M $23.23M -- -- --
Common Stock $163K $160K $156K $154K $162K $161K $158K $154K -- --
Retained Earnings -$1.67B -$1.70B -$1.70B -$696.4M -$937.6M -$1.47B -$1.57B -$1.59B -$1.31B -$1.19B
Accumulated Other Comp. Income -$1.06M $923K -$3.03M -- -- -- -- -- -$79K -$7.0K
Total Stockholders' Equity -$261.8M -$301.3M -$346.3M $652.4M $605.9M $62.64M -$93.25M -$196.4M $9.85M $66.72M
Total Equity -$261.8M -$301.3M -$346.3M $652.4M $605.9M $62.64M -$93.25M -$196.4M $9.85M $66.72M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $86.38M $79.13M $220.5M $215.5M $140.4M $92.85M $108.5M $88.56M
Cash & Short-Term Investments $86.38M $79.13M $220.5M $215.5M $140.4M $92.85M $108.5M $88.56M
Accounts Receivable, Net $132.7M $112.7M $105.8M $46.74M $120.4M $86.17M $39.77M $81.89M
Total Current Assets $226.0M $199.2M $332.3M $274.2M $273.8M $191.8M $160.6M $182.4M
Property, Plant & Equipment, Net $2.66M $2.91M $3.17M $3.41M $3.67M $3.93M $4.26M $4.50M
Intangible Assets $1.43M $1.63M $1.84M $2.04M $2.25M $2.45M $2.66M $2.86M
Other Non-Current Assets $3.60M $3.87M $4.14M $4.50M $4.84M $5.15M $5.54M $5.92M
Total Non-Current Assets $64.60M $85.93M $102.3M $122.7M $122.2M $151.2M $166.6M $168.5M
Total Assets $290.6M $285.1M $434.6M $396.9M $396.1M $342.9M $327.2M $350.9M
Accounts Payable $3.62M $911K $3.24M $2.90M $1.61M $1.39M $5.83M $2.13M
Deferred Revenue (Current) $1.26M $1.25M $1.47M $1.11M $1.05M $978K $1.80M $2.03M
Total Current Liabilities $34.73M $32.85M $236.3M $242.2M $242.5M $232.5M $48.10M $38.85M
Long-Term Debt -- -- -- -- $199.5M $199.3M $199.2M $199.0M
Other Non-Current Liabilities $20.14M $20.54M $21.17M $21.65M $22.22M $22.47M $17.29M $17.11M
Total Non-Current Liabilities $353.1M $414.1M $415.4M $416.5M $417.7M $418.6M $613.2M $613.4M
Total Liabilities $387.8M $447.0M $651.7M $658.7M $660.2M $651.1M $661.3M $652.2M
Total Debt (incl. Leases) $11.21M $11.87M $12.50M $13.12M $213.2M $213.7M $214.1M $214.5M
Common Stock $166K $165K $165K $163K $163K $162K $162K $160K
Retained Earnings -$1.52B -$1.58B -$1.63B -$1.67B -$1.67B -$1.71B -$1.74B -$1.70B
Accumulated Other Comp. Income $196K -$324K -$795K -$1.06M -$1.71M -$2.03M $294K $923K
Total Stockholders' Equity -$97.19M -$161.8M -$217.1M -$261.8M -$264.2M -$308.2M -$334.1M -$301.3M
Total Equity -$97.19M -$161.8M -$217.1M -$261.8M -$264.2M -$308.2M -$334.1M -$301.3M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income $24.02M $880K -$1.03B $175.1M $528.4M $106.2M $21.50M -$282.4M -$116.9M -$81.71M
Depreciation & Amortization $1.10M $1.20M $1.20M $1.40M $1.50M $2.30M $5.60M $3.90M $6.40M $10.28M
Stock-Based Compensation $17.25M $29.85M $32.01M $27.05M $22.28M $31.18M $31.28M $40.53M $30.91M $29.22M
Change in Receivables $35.15M $47.24M $924K $7.99M $7.71M $4.09M -$68.89M $1.21M -$17.30M -$10.34M
Change in Inventory -- -- -- -- -- $648K -- -$806K $346K --
Operating Cash Flow $127.0M $103.5M $183.4M $273.8M $261.9M $168.8M $10.72M -$70.88M -$100.8M -$25.93M
Capital Expenditure -$34K -$142K -$273K -$136K -$265K -$1.84M -$7.19M -$351K -$2.80M -$4.21M
Free Cash Flow $127.0M $103.4M $183.2M $273.6M $261.6M $167.0M $3.54M -$71.23M -$103.6M -$30.14M
Purchases of Investments -- -- -- -- -- -- -- -$3.24M -$191.4M -$311.1M
Investing Cash Flow -$34K -$142K -$1.03B -$136K -$265K -$1.84M -$11.14M $88.87M $151.5M -$177.7M
Share Repurchases -- -- -- -$126.4M -$24.13M -- -- -- -- --
Financing Cash Flow $216K -$107.0M $277.2M -$237.6M -$4.55M $18.55M -$1.19M $30.07M $19.84M -$4.18M
Net Change in Cash $126.9M -$3.60M -$565.8M $36.07M $257.1M $185.5M -$1.60M $48.06M $70.54M -$207.8M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income $59.84M $51.29M $40.77M -$2.28M $40.08M $23.60M -$37.39M $2.26M
Depreciation & Amortization $459K $457K $443K $460K $475K $467K $479K $485K
Stock-Based Compensation $4.29M $3.24M $3.65M $3.82M $3.61M $4.52M $5.29M $4.57M
Change in Receivables -$19.99M -$6.89M -$59.10M $73.62M -$34.19M -$46.40M $42.12M -$5.68M
Operating Cash Flow $67.40M $58.28M $5.12M $74.58M $47.58M -$15.07M $19.95M $15.21M
Capital Expenditure -- -- -- $1.0K -$2.0K -$2.0K -$31K $0
Free Cash Flow -- -- -- $74.58M $47.58M -$15.07M $19.92M $15.21M
Investing Cash Flow -- -- -- $1.0K -$2.0K -$2.0K -$31K $0
Financing Cash Flow -- -- -- $122K $0 $88K $6.0K -$14.89M
Net Change in Cash $7.25M -$141.3M $5.01M $75.05M $47.55M -$15.63M $19.92M $348K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin -- -- -- -- -- 99.2% 94.4% 90.6% 93.6% 99.3%
Operating Margin 33.3% 26.5% -213.5% 61.0% 56.1% 36.7% 28.0% -43.5% -5.2% -18.9%
Net Profit Margin 8.1% 0.3% -226.4% 42.6% 127.7% 27.3% 5.0% -81.5% -39.2% -29.8%
Return on Equity (ROE) -- -- -- 26.8% 87.2% 169.5% -- -- -1187.4% -122.5%
Return on Assets (ROA) 6.1% 0.3% -212.8% 15.9% 46.9% 19.0% 5.3% -85.0% -19.3% -11.5%
Current Ratio 1.13x 4.69x 0.84x 30.58x 4.61x 15.41x 7.50x 2.23x 4.72x 4.17x
Quick Ratio 1.08x 4.39x 0.80x 30.23x 4.54x 15.07x 7.48x 1.62x 4.71x 4.16x
Debt to Equity -- -- -- 0.64x 0.79x 7.24x -- -- -- --
Revenue Growth (YoY) -15.7% -20.6% +7.8% -0.8% +6.2% -9.1% +23.6% +16.2% +8.9% +83.2%
Gross Profit Growth (YoY) -- -- -- -- -- -4.5% +28.9% +12.4% +2.6% +81.9%
Operating Income Growth (YoY) +5.8% -- -477.7% +7.8% +62.5% +19.0% -- -- -- --
Net Income Growth (YoY) +2629.2% -- -672.5% -66.9% +397.7% +393.7% -- -- -- --
EPS Growth (YoY) +1400.0% -- -670.8% -65.3% +386.6% +378.6% -- -- -- --
Operating Cash Flow Growth (YoY) +22.7% -43.5% -33.0% +4.5% +55.1% +1474.2% -- -- -- --
Free Cash Flow Growth (YoY) +22.8% -43.5% -33.1% +4.6% +56.7% +4622.7% -- -- -- --
5Y Revenue / Share Growth -25.1% -19.6% +25.4% +32.9% +34.9% +132.2% +391.5% +1049.9% +41.8% +186.6%
10Y Revenue / Share Growth +73.9% +295.4% +1342.2% +88.4% +286.7% +399.5% -43.1% -- -- --
5Y Net Income / Share Growth -77.7% -96.0% -- -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin 62.9% 60.1% 55.4% 33.3% 36.3% 23.8% 16.7% 26.5%
Net Profit Margin 37.4% 33.4% 28.3% 8.1% 8.4% -2.6% -10.2% 0.3%
Return on Assets (ROA) 51.5% 45.5% 23.5% 6.1% 7.2% -2.3% -9.9% 0.3%
Current Ratio 6.51x 6.06x 1.41x 1.13x 1.13x 0.82x 3.34x 4.69x
Quick Ratio 6.31x 5.84x 1.38x 1.08x 1.08x 0.77x 3.08x 4.39x
Revenue Growth (YoY) +9.0% +32.6% +158.9% -47.3% +33.3% -9.7% -45.1% -23.0%
Operating Income Growth (YoY) +23.4% +75.0% -- -78.4% +194.4% +81.5% -364.1% -16.2%
Net Income Growth (YoY) +49.3% +117.3% -- -200.9% +999.3% -- -- --
EPS Growth (YoY) +44.0% +106.7% -- -200.0% +1150.0% -- -- --
Operating Cash Flow Growth (YoY) +41.6% -- -74.3% +390.2% +381.4% -145.0% -55.6% -57.5%
Free Cash Flow Growth (YoY) -- -- -- +390.2% +382.1% -145.1% -55.6% -57.3%
Source: SEC EDGAR CompanyFacts (CIK 0001446847) · from December 31, 2009 Data through September 30, 2026 · synced Nov 20, 2026, 05:32 UTC · Open in terminal